Vilya

📍 South San Francisco, United States👥 49 employees💰 Last funded Jun 2024
Biotechnology Research🌐 vilyatx.com
Website LinkedIn
Vilya is a cutting-edge computational biotechnology company, co-founded a team of scientists from from the Institute of Protein Design (IPD) led by David Baker, Ph.D. and by ARCH Venture Partners. At Vilya, we are creating a novel class of medicines to precisely target disease biology. Our platform is built on ground-breaking research in advanced computational approaches and taps into uncharted chemical space within cyclic peptides to design new molecular structures not found in nature. We aim to boldly leverage cutting edge computing to change how we design new medicines, and to ultimately cure diseases. Who will love working with us? We are a group of machine learning scientists, computational chemists, medicinal chemists, biologists and scientific enthusiasts that are driven to design and create life-altering medicines that will make a big impact on the world. Learn more about our job openings and join us! join@vilyatx.com
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2023–2024 · investors recorded per year
2023120242
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Vilya?
Vilya has 3 investors on record on gritt.io.
When did Vilya last raise funding?
The most recent investment in Vilya recorded on gritt.io was in June 2024.
What industry is Vilya in?
Vilya operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vilya based?
Vilya is headquartered in South San Francisco, United States.